This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Safety is a key concern for investors. Learn which option, index funds or individual stocks, offers better security for your investments.
24,450 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Celcuity stock popped today after the company released its 2025 results, showing a tighter quarterly loss despite no ...
Target delivered a solid beat-and-raise quarter, yet shares slid, illustrating a sell-the-news dynamic. With Walmart ...
Hewlett Packard Enterprise shares have climbed as demand for AI infrastructure accelerates. This article breaks down ...
Confused by Rocket Lab's stock moves? This guide explains the core forces behind RKLB, how the business is evolving, ...
Marvell Technology extended a dramatic rally, up 45% in a month on record revenue, while investors weigh whether to t...
Rocket Lab’s stock has faced renewed pressure as the market weighs contracting demand signals and execution risks. Th...
Sea Limited entertained investors with strong earnings yet faced a dramatic intraday drop driven by rising fintech co...
Two tobacco giants show divergent paths over 10 years, with dividend income boosting returns for both. Here's what ha...
Rumors swirl about SpaceX planning an IPO at a staggering $1.75 trillion. This article breaks down what that would me...
NVIDIA is at the center of AI-driven growth, and the latest update from CEO Jensen Huang has investors buzzing. This ...
In May, Grail stock surged on optimism about FDA approval timing and potential reimbursement for the Galleri MCED tes...